CORVUS PHARMACEUTICALS INC shareholders Q3 2023

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

CORVUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
JPMORGAN CHASE & CO 69,907$102,0640.00%
Citadel Advisors 31,300$45,6980.00%
Citadel Advisors 17,100$24,9660.00%
Citadel Advisors 183$2670.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 16,800$24,5280.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 53,400$77,9640.00%
VANGUARD GROUP INC 1,346,932$1,966,5210.00%
TWO SIGMA SECURITIES, LLC 11,232$16,3990.00%
HRT FINANCIAL LP 13,050$190.00%
SIMPLEX TRADING, LLC 39,493$570.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 127,968$186,8330.00%
UBS Group AG 6,700$9,7820.00%
COMMERCE BANK 20,000$29,2000.00%
RHUMBLINE ADVISERS 791$1,1540.00%
IFP Advisors, Inc 24$350.00%
BARCLAYS PLC 13,682$200.00%
OSAIC HOLDINGS, INC. 2,400$3,5040.00%
External links

This page lists CORVUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view CORVUS PHARMACEUTICALS INC's shareholder history, click here.